← FDA DRUG APPROVALS

FDA ANDA · ANDA210124

FLUOROURACIL

Sponsor: GLAND

APPLICATION
ANDA210124
TYPE
ANDA
ORIGINAL APPROVAL
2017-12-26
LATEST ACTION
2024-03-21
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

FLUOROURACILPrescription
FLUOROURACIL 5GM/100ML (50MG/ML) · INJECTABLE · INJECTION
FLUOROURACILPrescription
FLUOROURACIL 2.5GM/50ML (50MG/ML) · INJECTABLE · INJECTION

Approval history

2025-11-12Labeling · Supplement 12 · standard — Letter ↗TA
2024-03-21Labeling · Supplement 9 · standard — Letter ↗AP
2022-09-14Labeling · Supplement 4 · standardAP
2017-12-26UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →